|
Index of reports
> Cases resulting in life threatening events (9)
Below is the selection of adverse event reports related to Flagyl (Metronidazole) that includes cases resulting in life threatening events.
Adverse event in 84 year old male receiving Flagyl (Metronidazole)
Reported by a individual with unspecified qualification on 2007-07-31
Patient: 84 year old male
Adverse reactions / side effects: Shock Haemorrhagic, Rectal Haemorrhage, Drug Interaction, Haemorrhagic Anaemia, Prothrombin Time Ratio Decreased
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Oflocet / 00731801 /
Start date: 2007-02-14
Flagyl
Start date: 2007-02-14
Previscan / 00789001 /
Administration route: Oral
Indication: Arrhythmia
End date: 2007-02-15
Other drugs received by patient: EPO
Adverse event in female receiving Flagyl (Metronidazole)
Reported by a consumer/non-health professional from United States on 2007-05-14
Patient: female
Adverse reactions / side effects: Anaphylactic Shock
Adverse event resulted in: life threatening event
Suspect drug(s):
Cetirizine HCL
Indication: Urticaria
Flagyl
Indication: Vaginal Infection
Adverse event in 79 year old female receiving Flagyl (Metronidazole)
Reported by a individual with unspecified qualification on 2007-04-17
Patient: 79 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Overdose, Haematuria, Anuria, Renal Failure Acute
Adverse event resulted in: life threatening event
Suspect drug(s):
Flagyl
Start date: 2006-11-03
Clamoxyl / 00249601 /
Start date: 2006-11-01
End date: 2006-11-09
Adverse event in male receiving Flagyl (Metronidazole)
Reported by a consumer/non-health professional from United States on 2007-03-21
Patient: male, weighing 65.8 kg (144.7 pounds)
Adverse reactions / side effects: Angioedema, Crohn's Disease, Dehydration, Drug Hypersensitivity
Adverse event resulted in: life threatening event
Suspect drug(s):
Flagyl
Dosage: 500 mg 3 times daily po
Administration route: Oral
Indication: Crohn's Disease
Start date: 2006-02-01
End date: 2006-02-04
Flagyl
Dosage: 500 mg 3 times daily po
Administration route: Oral
Indication: Giardiasis
Start date: 2006-02-01
End date: 2006-02-04
Adverse event in 79 year old female receiving Flagyl (Metronidazole)
Reported by a individual with unspecified qualification on 2007-02-27
Patient: 79 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Overdose, Haematuria, Anuria, Renal Failure Acute
Adverse event resulted in: life threatening event
Suspect drug(s):
Flagyl
Start date: 2006-11-03
Clamoxyl / 00249601 /
Start date: 2006-11-01
End date: 2006-11-09
Adverse event in 53 year old male receiving Flagyl (Metronidazole)
Reported by a pharmacist from France on 2007-02-08
Patient: 53 year old male, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Hepatitis Cholestatic
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Moxifloxacin Hydrochloride
Dosage: total daily dose: 400 mg unit dose: 400 mg
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Flagyl
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Vfend
Dosage: unit dose: 200 mg
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-13
End date: 2006-12-01
Other drugs received by patient: Xatral; Nicotinell; Motylio; Xanax
Adverse event in 53 year old male receiving Flagyl (Metronidazole)
Reported by a individual with unspecified qualification on 2007-01-31
Patient: 53 year old male
Adverse reactions / side effects: Metabolic Acidosis, Coagulopathy, Cholestasis, Pyrexia, Hepatitis Cholestatic, Renal Failure, Sepsis, Circulatory Collapse, Leukocytosis, Cardiovascular Disorder
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Flagyl
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Moxifloxacin Hydrochloride
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-07
End date: 2006-12-01
Vfend
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-13
End date: 2006-12-01
Adverse event in 53 year old male receiving Flagyl (Metronidazole)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-26
Patient: 53 year old male, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Hepatitis, Cardiac Arrest
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Vfend
Administration route: Oral
Indication: Aspergillosis
Start date: 2006-11-13
End date: 2006-12-01
Moxifloxacin Hydrochloride
Administration route: Oral
Start date: 2006-11-07
End date: 2006-12-01
Flagyl
Administration route: Oral
Start date: 2006-11-09
End date: 2006-12-01
Adverse event in 53 year old male receiving Flagyl (Metronidazole)
Reported by a individual with unspecified qualification on 2007-01-16
Patient: 53 year old male
Adverse reactions / side effects: Metabolic Acidosis, Coagulopathy, Cholestasis, Pyrexia, Hepatitis Cholestatic, Renal Failure, Sepsis, Circulatory Collapse, Leukocytosis
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Flagyl
Administration route: Oral
Start date: 2006-11-07
End date: 2006-12-01
Moxifloxacin Hydrochloride
Administration route: Oral
Start date: 2006-11-07
End date: 2006-12-01
Vfend
Administration route: Oral
Start date: 2006-11-13
End date: 2006-12-01
|
